PointState Capital’s Exelixis EXEL Stock Holding History

PointState Capital’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-500,000	Closed	-$7.46M	–	141
2016 Q4	$7.46M	Hold	500,000	–	–	0.11%	92
2016 Q3	$6.39M	Buy	+500,000	New	+$5.41M	0.07%	98

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PointState Capital's EXEL Position: Q1 2017 in Review

PointState Capital sold out of Exelixis (EXEL) in Q1 2017, closing a stake of 500,000 shares — an estimated $7.46M sold.

PointState Capital first reported a position in EXEL in Q3 2016 and held it in 2 quarters. The position peaked at $7.46M in Q4 2016. 229 funds tracked by Wall St. Rank hold EXEL as of Q1 2017.

PointState Capital reported no remaining Exelixis position as of Q1 2017 after selling out during the quarter.
PointState Capital sold 500,000 Exelixis shares in Q1 2017, an estimated $7.46M.
PointState Capital first reported a position in Exelixis in Q3 2016 and held it in 2 quarters.
PointState Capital's Exelixis position peaked at $7.46M in Q4 2016.
229 funds tracked by Wall St. Rank held Exelixis as of Q1 2017.

Based on PointState Capital's 13F filing for Q1 2017, filed 15 May 2017.